Targeting Alzheimer's Disease: Groundbreaking Research and Care Insights

Join us as Dr. Jim Ray discusses the scientific challenges of Alzheimer’s disease, why existing drugs have failed and the strategies that Neurodegeneration Consortium scientists have developed to detect and slow or stop its progression. Afterwards, he’ll join a specially selected panel of experts to answer questions. They’ll provide insights into research, resources, how to improve quality of life, and the family journey. Space is limited. RSVP required.

The Neurodegeneration Consortium (NDC) is a transformational collaboration among Baylor College of Medicine, the Massachusetts Institute of Technology and The University of Texas MD Anderson Cancer Center. NDC scientists are dedicated to discovering new ways to target Alzheimer’s disease in efforts to slow, stop, or reverse its progression. After more than a decade with no new drugs and no existing drugs that can slow the disease, a new generation of drug candidates has started late stage clinical trials. For more information about NDC, visit www.neurodegeneration-consortium.org